--- title: Diagnostic Nuclear Medicine | Blue Earth Diagnostics description: Learn more about diagnostic nuclear medicine. Molecular imaging uses radioisotopes attached to a targeting molecule to diagnose diseases such as cancer. --- You are leaving the Blue Earth Diagnostics website. By clicking this link, you will be taken to a website that is independent from Blue Earth Diagnostics. The site you are linking to is not controlled or endorsed by Blue Earth Diagnostics and Blue Earth Diagnostics is not responsible for the content provided on that site. BEDUK-N/A-2500011  March 2025   ACCEPT CANCEL [![BED-Logo-2026](https://www.blueearthdiagnostics.com/hs-fs/hubfs/BED-Logo-2026.png?width=632&height=126&name=BED-Logo-2026.png "BED-Logo-2026")](https://www.blueearthdiagnostics.com) - [Home](https://www.blueearthdiagnostics.com) - [About](https://www.blueearthdiagnostics.com/about) - Team - [Board of Directors](https://www.blueearthdiagnostics.com/board) - [Management Team](https://www.blueearthdiagnostics.com/management) - [Technology](https://www.blueearthdiagnostics.com/technology) - [Nuclear Medicine](https://www.blueearthdiagnostics.com/technologies/nuclear-medicine/) - [Diagnostic Nuclear Medicine](https://www.blueearthdiagnostics.com/technologies/diagnostic-nuclear-medicine/) - [Therapeutic Nuclear Medicine](https://www.blueearthdiagnostics.com/technologies/therapeutic-nuclear-medicine/) - [Positron Emission Tomography (PET) Imaging](https://www.blueearthdiagnostics.com/technologies/positron-emission-tomography/) - Products - [Clinical Trials](https://www.blueearthdiagnostics.com/clinical-trials) - [Products](https://www.blueearthdiagnostics.com/products) - [R&D PIPELINE](https://www.blueearthdiagnostics.com/pipeline) - [Healthcare Professionals](https://www.blueearthdiagnostics.com/healthcare-professionals) - [Patients](https://www.blueearthdiagnostics.com/patients) - Partnering - [Research Partnerships](https://www.blueearthdiagnostics.com/research-partnerships) - [Donations and Grants](https://www.blueearthdiagnostics.com/donations-and-grants) - [Disclosures](https://www.blueearthdiagnostics.com/disclosures) - [Media](https://www.blueearthdiagnostics.com/news) - [Events](https://www.blueearthdiagnostics.com/conferences) - [Careers](https://www.blueearthdiagnostics.com/careers) - [Contact](https://www.blueearthdiagnostics.com/contact) [Follow us on LinkedIn ](https://www.linkedin.com/company/blue-earth-diagnostics-ltd-/) # DIAGNOSTIC NUCLEAR MEDICINE Diagnostic nuclear medicine is a type of molecular imaging that uses very small amounts of radioisotopes attached to a targeting molecule (radiopharmaceutical1) to diagnose complex diseases such as cancer. Radiopharmaceuticals are able to show the physiological function of the body rather than just the anatomy. Changes in the biochemical activity of cells often characterises disease. For example, cancer cells multiply at a much faster rate and are more active than normal cells, therefore and often have a high demand for precursors such as amino acids to build proteins. Radiopharmaceuticals can provide images of what is occurring inside the body at molecular and cellular levels. Depending upon where the patient is in the course of their disease, such a unique insight into the human body may enable physicians to personalise patient care. Source [1http://www.snmmi.org/AboutSNMMI/Content.aspx?ItemNumber=5646](http://www.snmmi.org/AboutSNMMI/Content.aspx?ItemNumber=5646)   UKBED-N/A-2600048 / April 2026 [![BED-Logo-2026-White](https://www.blueearthdiagnostics.com/hs-fs/hubfs/BED-Logo-2026-White.png?width=530&height=106&name=BED-Logo-2026-White.png) ](https://www.blueearthdiagnostics.com)  Blue Earth Diagnostics is an established molecular imaging company on a growth trajectory to provide innovative, well differentiated diagnostics solutions, informing patients and driving future therapies in cancer. Formed in 2014, Blue Earth Diagnostics' success is driven by our management expertise and agility, supported by our demonstrated track record of rapid development and commercialisation of PET radiopharmaceuticals. Blue Earth Diagnostics’ clinical focus is exclusively in cancer.  READ MORE Quick Links --- - [About](https://www.blueearthdiagnostics.com/about) - [Contact](https://www.blueearthdiagnostics.com/contact) - [Team](https://www.blueearthdiagnostics.com/management) - [Intellectual Property](https://www.blueearthdiagnostics.com/intellectual-property) - [Privacy Policy](https://www.blueearthdiagnostics.com/hubfs/BlueEarthDiagnostics_Sept2018/BED%20Website%20Privacy%20Statement%202024%200717.pdf) - [Events](https://www.blueearthdiagnostics.com/conferences) - [Cookie Policy](https://www.blueearthdiagnostics.com/cookie-policy) - [Media](https://www.blueearthdiagnostics.com/news) - [Modern Slavery Statement](https://www.blueearthdiagnostics.com/hubfs/BlueEarthBackup/Modern%20Slavery%20Statement/Modern%20Slavery%20Statement.pdf) - [Code of Ethics](https://www.blueearthdiagnostics.com/hubfs/Bracco-Code-of-Ethics-Oct-2021.pdf) - [Careers](https://www.blueearthdiagnostics.com/careers) - [Community Guidelines](https://www.blueearthdiagnostics.com/community-guidelines) Contact Information --- The Oxford Science Park Magdalen Centre, Robert Robinson Avenue Oxford OX4 4GA - [ +44 (0)1865 507300 ](tel:+44%20(0)1865%20784%20186) - [ contact@blueearthDx.com ](mailto:contact@blueearthdx.com) ---  © Blue Earth Diagnostics 2026. All Rights Reserved. Developed by [RevM](https://www.revm.com/)